Specification sheet
PT-141
- Molecular weight
- 1025.2g/mol
- Formula
- C50H68N14O10
- CAS number
- 189691-06-3
Sequence
Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
- Type
- Synthetic peptide
- Form
- Lyophilized powder
- Sizes
- 10mg
Research access
Lumen supplies research compounds to qualified researchers and laboratories for in-vitro use. Confirm once to enter.
By entering you affirm the statement above is true. Products are not for human or veterinary use, not for diagnostic procedures, and have not been evaluated by the FDA.
99.95%HPLC purity
Cognitive / Neuro Research
Cyclic melanocortin heptapeptide studied via central pathways.
$45.0010mg vial
Buy 1, get 1 free: add a 2nd vial and it is free.
Researchers also added
Mix and match: Buy 1, get 1 free pairs any two vials in your cart. Research use only.
The compound
PT-141 (bremelanotide) is a cyclic seven-residue melanocortin analog derived from alpha-MSH. Research interest centres on its central, receptor-mediated mechanism, which is distinct from the peripheral vascular pathways studied for other compounds. Research use only.
Specification sheet
Sequence
Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
Where it is studied
Agonism at melanocortin-4 receptors is the primary mechanism studied in CNS models.
Investigated for modulation of hypothalamic circuits rather than peripheral vasculature.
The cyclised backbone confers stability relative to linear alpha-MSH fragments.
In the lab
PT-141 (bremelanotide) is a cyclic alpha-MSH analog that activates several melanocortin receptor subtypes, with MC4R the most discussed. Lab work links it to dopamine release in the hypothalamus and to MC3/MC4-dependent survivin loss in glioblastoma cells.

Compound
PT-141Cyclic peptide analog of alpha-MSHMedial preoptic neurons
Endpoint studied
Dopamine releaseReviewed lab work points to presynaptic MC4R on medial preoptic neurons raising dopamine release.Pfaus 2022 · PMID 33455598 (opens PubMed in a new tab)Glioblastoma cells
Endpoint studied
Glioblastoma cell deathLess survivin and more cell death, both canceled by an MC3/MC4 antagonist; normal human cells were spared.Suzuki 2024 · PMID 39197897 (opens PubMed in a new tab)Research history
5 milestones, each linked to its PubMed record.
2007
The Journal of Sexual Medicine
A review of lab work maps its action to the medial preoptic area of the brain.
PubMed · PMID 17958619 (opens in a new tab)2022
CNS Spectrums
A review: PT-141 activates several melanocortin receptors; presynaptic MC4R in the medial preoptic area may raise dopamine release.
PubMed · PMID 33455598 (opens in a new tab)2024
Anticancer Research
Survivin falls and glioblastoma cells die, effects canceled by blocking MC3 and MC4 receptors.
PubMed · PMID 39197897 (opens in a new tab)2025
Neuropharmacology
MC3R and MC4R mRNA sit mostly in VTA dopamine neurons; PT-141 did not change their expression.
PubMed · PMID 39793696 (opens in a new tab)2026
Analytical Methods
Stress testing finds eight degradation products, formed by deacetylation, peptide-bond hydrolysis, oxidation and epimerization.
PubMed · PMID 42485063 (opens in a new tab)Laboratory research only, cited for research context. Not a claim about use in people.
Catalog peptides are specified at 99%+ identity purity. Each lot is verified by an independent laboratory using HPLC and mass spectrometry, and the results are published in that lot's Certificate of Analysis.
A COA is the lab document issued for a specific production lot. It records the compound's identity confirmation, measured purity and the lot number, so the vial on the bench can be traced back to its test results.
Orders placed before the daily cutoff ship the same or next business day from a US facility. Lyophilized peptides are stable in transit and do not require cold shipping.
L-H2O is a sterile, USP-grade laboratory solvent containing 0.9% benzyl alcohol. It is a bench accessory, not a peptide, and carries no HPLC purity claim or COA.
Research use only. Sold strictly for in-vitro laboratory research by qualified professionals. Not for human or veterinary use, not for diagnostic or therapeutic procedures, and not evaluated by the FDA.